Utah Snags $24 Million in Eli Lilly and Company (JOBS) Drug Settlement
sltrib.com -- A four-year investigation into a pharmaceutical giant's alleged off-label marketing of an anti-psychotic drug has earned a $24 million settlement for Utah. "This isn't just about money," Utah Attorney General Mark Shurtleff said Wednesday. "The victims were those who could least afford health care."